Literature DB >> 6858121

Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease.

L Gurian, K Klein, T T Ward.   

Abstract

Findings from recent studies on the role of Clostridium difficile and Campylobacter jejuni in exacerbations of inflammatory bowel disease are in conflict. We examined stool specimens from 32 patients who had inflammatory bowel disease in relapse for the presence of C difficile and C difficile cytotoxin. In the last 19 cases stool specimens were also cultured for C jejuni. C difficile was identified in one patient who was receiving antimicrobial therapy. In no patient was C difficile cytotoxin detected. All cultures for C jejuni were negative. Routine screening of stool specimens for C difficile cytotoxin and C jejuni was not clinically useful in our patients during exacerbation of their inflammatory bowel disease.

Entities:  

Mesh:

Year:  1983        PMID: 6858121      PMCID: PMC1021467     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  14 in total

1.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

Review 2.  Antibiotic-associated colitis.

Authors:  J G Bartlett
Journal:  Clin Gastroenterol       Date:  1979-09

3.  Campylobacter jejuni causing flare-up in inflammatory bowel disease.

Authors:  A Newman; J R Lambert
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

4.  Colitis induced by Clostridium difficile.

Authors:  J G Bartlett; T Chang; N S Taylor; A B Onderdonk
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

5.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

6.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

7.  Is pseudomembranous colitis infectious?

Authors:  C Greenfield; A Burroughs; M Szawathowski; N Bass; P Noone; R Pounder
Journal:  Lancet       Date:  1981-02-14       Impact factor: 79.321

8.  Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease?

Authors:  R P Bolton; R J Sherriff; A E Read
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

9.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

10.  Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease.

Authors:  J T LaMont; Y M Trnka
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

View more
  3 in total

1.  Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.

Authors:  Preetika Sinh; Terrence A Barrett; Laura Yun
Journal:  Gastroenterol Res Pract       Date:  2011-09-12       Impact factor: 2.260

Review 2.  Management of inflammatory bowel disease with Clostridium difficile infection.

Authors:  Julie D'Aoust; Robert Battat; Talat Bessissow
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

3.  MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.

Authors:  C Rodríguez; E Romero; L Garrido-Sanchez; G Alcaín-Martínez; R J Andrade; B Taminiau; G Daube; E García-Fuentes
Journal:  Gut Microbes       Date:  2020-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.